Table 1 Characteristics of the Patients.
Characteristics | Values(%) |
|---|---|
Median age (range), years | 66 (37–89) |
Sex, n (%) | |
Male | 26 (81.3) |
Female | 6 (18.8) |
ECOG performance status, n (%) | |
0 | 26 (81.3) |
1 | 4 (12.5) |
2 | 2 (6.3) |
Smoking, n (%) | |
Yes | 9 (28.1) |
No | 23 (71.9) |
Prior BCG status, n (%) | |
BCG-unresponsive | 7 (21.9) |
BCG-ineligible | 25 (78.1) |
Prior radiation therapy, n (%) | |
Yes | 5 (15.6) |
No | 27 (84.4) |
T stage, n (%) | |
CIS | 2 (6.3) |
Ta | 2 (6.3) |
T1 | 28 (87.5) |
HER2 status, n (%) | |
1+ | 2 (6.3) |
2+ | 11 (34.4) |
3+ | 19 (59.4) |
RC48 treatment regimens, n (%) | |
RC48 alone | 3 (9.4) |
RC48 in combination with PD-1 inhibitors | 29 (90.6) |
Toripalimab | 19 |
Tislelizumab | 7 |
Pembrolizumab | 3 |
